The collaboration is funded by the Mayo Clinic Center for Individualized Medicine and led by the center’s medical director, Dr. Keith Stewart.
Under the agreement, healthy patients who participate in a Mayo Clinic research study will receive a whole-genome sequencing screening test through Veritas Genetics’ flagship product, myGenome. Mayo Clinic researchers will offer clinical feedback to the Veritas Genetics team.
Mayo Clinic, which will also become a Veritas shareholder, says it will use any revenue it receives as a result of the collaboration to support its nonprofit mission to drive healthcare.
More articles on data analytics & precision medicine:
Microsoft partners with Adaptive Biotechnologies to ‘decode’ immune systems with AI
Vanderbilt-Ingram Cancer Center enters precision medicine collaboration with Tempus
4 questions with PotentiaMetrics CEO Robert Palmer on personalized healthcare
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
